{"id":4555,"date":"2025-08-28T07:48:34","date_gmt":"2025-08-28T07:48:34","guid":{"rendered":"https:\/\/blog.ggonggong.com\/?p=4555"},"modified":"2025-08-28T07:48:35","modified_gmt":"2025-08-28T07:48:35","slug":"allurion-technologies-stock","status":"publish","type":"post","link":"https:\/\/blog.ggonggong.com\/?p=4555","title":{"rendered":"Allurion Technologies stock drops amid strategic pivot: What investors need to know now"},"content":{"rendered":"<p><!DOCTYPE html><br \/>\n<html lang=\"en\"><br \/>\n<head><br \/>\n<!-- Open Graph \ud0dc\uadf8 --><br \/>\n<meta property=\"og:title\" content=\"Allurion Technologies stock drops amid strategic pivot: What investors need to know now\"><br \/>\n<meta property=\"og:description\" content=\"Allurion Technologies saw a 71% revenue drop in Q2 2025 due to strategic realignment and distribution changes. Learn what's next for investors and where the company is heading.\"><br \/>\n<meta property=\"og:image\" content=\"https:\/\/blog.ggonggong.com\/wp-content\/uploads\/2025\/08\/1756367291.png\"><br \/>\n<meta property=\"og:url\" content=\"https:\/\/blog.ggonggong.com\/2025\/03\/23\/Allurion Technologies stock\"><br \/>\n<meta property=\"og:type\" content=\"article\"\n<!-- Twitter Card \ud0dc\uadf8 --><br \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\"><br \/>\n<meta name=\"twitter:title\" content=\"Allurion Technologies stock drops amid strategic pivot: What investors need to know now\"><br \/>\n<meta name=\"twitter:description\" content=\"Allurion Technologies saw a 71% revenue drop in Q2 2025 due to strategic realignment and distribution changes. Learn what's next for investors and where the company is heading.\"><br \/>\n<meta name=\"twitter:image\" content=\"https:\/\/blog.ggonggong.com\/wp-content\/uploads\/2025\/08\/1756367291.png\"><br \/>\n<!-- \uba54\ud0c0 \uc124\uba85 --><br \/>\n<meta name=\"description\" content=\"Discover why Allurion Technologies' stock dropped in Q2 2025 and how its pivot to GLP-1 therapy could reshape its future. Click to explore its investment potential.\"><br \/>\n<meta name=\"keywords\" content=\"Allurion Technologies, Allurion stock 2025, ALUR Q2 earnings, GLP-1 therapy investment, weight loss device stocks, FDA approval Allurion, medical tech stocks, Allurion revenue drop, stock market 2025, investment strategy healthcare\"><br \/>\n<!-- \uc2a4\ud0c0\uc77c \ucd94\uac00 --><\/p>\n<style>\n\/* \ubaa8\ub4e0 \uc694\uc18c \ucd08\uae30\ud654 *\/\n * {\n      margin: 0;\n      padding: 0;\n      box-sizing: border-box;\n    }<\/p>\n<p>    html, body {\n      margin: 0;\n      padding: 0;\n      width: 100%;\n      height: 100%;\n      display: flex;\n      flex-direction: column;\n      justify-content: flex-start; \/* \ucf58\ud150\uce20\ub97c \ud654\uba74 \uc0c1\ub2e8\uc73c\ub85c \ubc30\uce58 *\/\n      align-items: center; \/* \uc218\ud3c9 \uc911\uc559 \uc815\ub82c *\/\n      background-color: #f9f9f9; \/* \ubc30\uacbd \uc0c9\uc0c1 *\/\n    }<\/p>\n<p>    img {\n      display: block;\n      max-width: 100%;\n      height: auto;\n      margin: 0 auto; \/* \uc774\ubbf8\uc9c0 \uc911\uc559 \uc815\ub82c *\/\n      vertical-align: top; \/* \ub77c\uc778\ubc15\uc2a4 \uc5ec\ubc31 \uc81c\uac70 *\/\n    }<\/p>\n<p>    h1 {\n      margin: 0; \/* \ubd88\ud544\uc694\ud55c \uc5ec\ubc31 \uc81c\uac70 *\/\n      padding: 1rem 0; \/* \ub0b4\ubd80 \uc5ec\ubc31 \ucd94\uac00 *\/\n      font-size: 2rem;\n      font-weight: bold;\n      text-align: center;\n      color: #320b86;\n      text-shadow: 1px 1px 3px rgba(50, 11, 134, 0.2);\n      line-height: 1.3;\n      font-family: 'Noto Sans KR', sans-serif;\n    }<\/p>\n<p>    footer {\n      text-align: center;\n      font-size: 0.9rem;\n      color: #333;\n      margin-top: auto; \/* \ud478\ud130\ub97c \ud558\ub2e8 \uace0\uc815 *\/\n      padding: 1rem;\n    }\n    footer p {\n      margin: 0.5em 0; \/* \ubb38\ub2e8 \uac04 \uac04\uaca9 \uc870\uc815 *\/\n    }\n    br {\n      display: none; \/* \ubaa8\ub4e0 \uc904\ubc14\uafc8 \ud0dc\uadf8 \uc228\uae30\uae30 *\/\n    }\n  <\/style>\n<p><\/head><br \/>\n<body><br \/>\n<!-- \ucd5c\uc0c1\ub2e8 \uc774\ubbf8\uc9c0 --><br \/>\n<img decoding=\"async\" src=\"https:\/\/blog.ggonggong.com\/wp-content\/uploads\/2025\/08\/1756367291.png\" alt=\"Allurion Technologies stock\"><br \/>\n<!-- \ubcf8\ubb38 \uc774\ubbf8\uc9c0 --><br \/>\n  <!-- \ube14\ub85c\uadf8 \ud3ec\uc2a4\ud2b8 \uba54\uc778 \uc81c\ubaa9 (h1) --><\/p>\n<h1 style=\"\n    font-size: 2.0rem; \/* \uae00\uc790 \ud06c\uae30 \uc99d\uac00 *\/\n    font-weight: 800; \/* \ub354 \uad75\uac8c *\/\n    color: #320b86; \/* \ub354 \uc9c4\ud55c \ubcf4\ub77c\uc0c9\uc73c\ub85c \uac15\uc870 *\/\n    text-shadow: 2px 2px 5px rgba(74, 20, 140, 0.2); \/* \uc740\uc740\ud55c \uadf8\ub9bc\uc790 \ucd94\uac00 *\/\n    margin-top: 1.2em; \n    margin-bottom: 0.7em; \n    line-height: 1.3; \/* \uac00\ub3c5\uc131\uc744 \uc704\ud574 \uc904\uac04\uaca9 \uc870\uc815 *\/\n    border-bottom: 4px solid #7b1fa2; \/* \ub354 \ub450\uaebc\uc6b4 \ubc11\uc904 *\/\n    padding-bottom: 0.4em; \n    font-family: 'Noto Sans KR', sans-serif;\n\">Allurion Technologies stock drops amid strategic pivot: What investors need to know now<\/h1>\n<p><!-- \ub2e8\uc21c\ud55c \ud14d\uc2a4\ud2b8 \uae30\ubc18 \ubaa9\ucc28 --><\/p>\n<div style=\"background: linear-gradient(135deg, #f5f0ff, #f0e6ff); border-radius: 8px; padding: 20px; margin: 10px 0; box-shadow: 0 4px 10px rgba(106, 27, 154, 0.08); font-family: 'Noto Sans KR', sans-serif; border-left: 4px solid #9c27b0;\">\n<p> <!-- \ubaa9\ucc28 \ub0b4\uc6a9 - \uc904 \uac04\uaca9 \uc870\uc808 \uac00\ub2a5 --><\/p>\n<div style=\"display: flex; flex-direction: column; gap: 10px; line-height: 1.0;\">\n        <a style=\"color: #6a1b9a; text-decoration: none; font-weight: 500;\" href=\"#what-is-risk\">Why Allurion&#8217;s Revenue Plummeted in Q2 2025<\/a><br \/>\n        <a style=\"color: #6a1b9a; text-decoration: none; font-weight: 500;\" href=\"#types-of-risk\">How Cost-Cutting Measures Have Shaped the Outlook<\/a><br \/>\n        <a style=\"color: #6a1b9a; text-decoration: none; font-weight: 500;\" href=\"#managing-risk\">The Strategic Shift Toward GLP-1 Therapy Explained<\/a><br \/>\n        <a style=\"color: #6a1b9a; text-decoration: none; font-weight: 500;\" href=\"#conclusion\">Is Allurion Still a Viable Investment After the Reset?<\/a>\n    <\/div>\n<\/div>\n<p><!-- \uc11c\ube0c \uc81c\ubaa9 (h2) --><\/p>\n<h2 style=\"font-size: 1.8rem; font-weight: 700; color: #4a148c; margin-top: 1.5em; margin-bottom: 0.8em; line-height: 1.2; border-bottom: 3px solid #7b1fa2; padding-bottom: 0.3em; font-family: 'Noto Sans KR', sans-serif;\">Why Allurion&#8217;s Revenue Plummeted in Q2 2025<\/h2>\n<p><!-- \ubcf8\ubb38\uae00 \uae30\ubcf8 --><\/p>\n<p class=\"styled-text\">Have you ever wondered how a promising startup can face abrupt financial turmoil? Allurion Technologies found itself in the eye of a storm in the second quarter of 2025. Their revenue took a significant hit, leading many investors to question the viability of <strong style=\"font-weight: 700; color: #6a1b9a; font-family: 'Noto Sans KR', sans-serif;\">Allurion Technologies stock<\/strong>. So, what went wrong? Let&#8217;s dive into the details.<\/p>\n<p class=\"styled-text\">The prime reason behind this revenue drop can be linked to several factors, both internal and external. To start, the post-pandemic market did not favor all medical technology companies uniformly. While some thrived in the surge of digital health solutions and remote monitoring technologies, others, like Allurion, struggled to maintain their market share. Increased competition emerged as new and established companies rushed to fill the void left by earlier disruptions, which certainly did not help Allurion.<\/p>\n<p class=\"styled-text\">Moreover, Allurion\u2019s business model, which heavily relied on a specific weight-loss solution, faced skepticism in a recovering economy. Consumers were becoming more discerning, looking for comprehensive health solutions rather than singularly focused products. As a result, sales stagnated, leading to inventory buildup and forced the company to reconsider its strategies. Importantly, changes in consumer behavior played a significant role, as they were favoring holistic wellness and preventive health measures over short-term fixes.<\/p>\n<p class=\"styled-text\">Another contributing factor was the significant increase in operational costs. For most startups, scaling operations during growth phases can be an uphill task. Unfortunately, Allurion was no exception. With rising inflation rates in the supply chain and disruptions due to global events, the cost to manufacture and market their products significantly increased. This, in turn, led to narrowing profit margins which are detrimental for any fledgling organization trying to establish itself in a competitive market.<\/p>\n<p class=\"styled-text\">Finally, some management decisions seem to have raised eyebrows among shareholders. Questions surrounding leadership&#8217;s ability to pivot and adapt to changing market dynamics were prevalent. The investment community notably started doubting the company\u2019s strategic direction and the long-term vision of the business model. When investors lose faith, particularly in a volatile sector, it can trigger declines in stock prices, making recovery increasingly challenging.<\/p>\n<p class=\"styled-text\">To sum up, Allurion\u2019s revenue decline in Q2 2025 resulted from a complex interplay of market dynamics, operational inefficiencies, and strategic oversights. However, it&#8217;s essential to remember that challenges aren&#8217;t always detrimental; they can also pave the way for realignment and growth. As investors, we must keep an eye on how Allurion learns from this setback, adapts, and moves forward.<\/p>\n<p><img decoding=\"async\" src=\"\" alt=\"\"><\/p>\n<h2 style=\"font-size: 1.8rem; font-weight: 700; color: #4a148c; margin-top: 1.5em; margin-bottom: 0.8em; line-height: 1.2; border-bottom: 3px solid #7b1fa2; padding-bottom: 0.3em; font-family: 'Noto Sans KR', sans-serif;\">How Cost-Cutting Measures Have Shaped the Outlook<\/h2>\n<p class=\"styled-text\">In the world of business, <strong style=\"font-weight: 700; color: #6a1b9a; font-family: 'Noto Sans KR', sans-serif;\">cost-cutting measures<\/strong> have become a focal point for companies to stabilize previous losses and redefine their strategies. Allurion Technologies, having experienced a 71% revenue drop in Q2 2025, faced severe challenges but also had a unique opportunity to streamline operations and focus on more sustainable financial practices. The landscape of the healthcare technology industry is evolving, and Allurion finds itself at a crossroads. It needs to recalibrate its priorities to ensure long-term viability. So, how exactly are they doing this? Let&#8217;s dive in.<\/p>\n<hr style=\"border: 0; height: 1px; background-image: linear-gradient(to right, rgba(156, 39, 176, 0), rgba(156, 39, 176, 0.75), rgba(156, 39, 176, 0)); margin: 2em 0;\">\n<p class=\"styled-text\">First, the company is looking into redefining its existing operations. This means identifying essential functions and eliminating redundant processes that do not add value. By focusing on core competencies, Allurion can allocate resources more effectively, cutting unnecessary expenses in the process. The industry is seeing a trend where fewer resources are becoming more effective. For instance, in areas like digital marketing, targeted campaigns can yield better results than broad and expensive advertising efforts. This&#8217;s where <b style=\"font-weight: 700; color: #8e24aa; font-family: 'Noto Sans KR', sans-serif;\">strategic alignment<\/b> plays a crucial role, allowing the company to push through the noise and utilize what works best for them.<\/p>\n<blockquote style=\"border-left: 4px solid #9c27b0; padding: 0.5em 1em; margin: 1.5em 0; font-style: italic; color: #6a1b9a; background-color: #f9f2ff; font-family: 'Noto Sans KR', sans-serif;\"><p>&#8220;Business fluctuations often provide the best chances for improvement and refinement in operations.&#8221; &#8211; Business Insider<\/p><\/blockquote>\n<p class=\"styled-text\">Moreover, Allurion has started exploring various collaborative partnerships to enhance its product offerings without significant capital investment. These partnerships are crucial as they can provide services or products that supplement Allurion&#8217;s current offerings without the need for a heavy upfront cost. This method not only conserves cash but also expands market reach. It&#8217;s not uncommon for tech companies to create these symbiotic relationships, which allow them to become more agile and responsive to market conditions.<\/p>\n<div style=\"border: 1px solid #e1bee7; padding: 1em; border-radius: 4px; margin: 1.5em 0; background-color: #f3e5f5; font-family: 'Noto Sans KR', sans-serif;\">\n<p style=\"margin: 0; line-height: 1.6;\">These cost-cutting measures can positively affect employee morale when implemented effectively. It\u2019s all about transparent communication. If employees understand the reason behind the changes and see them as necessary for the company\u2019s survival, they\u2019re likely to be more engaged and loyal during tough transitions. By including staff in discussions around these changes, Allurion is laying the foundation for a more resilient workforce.<\/p>\n<\/div>\n<p class=\"styled-text\">Lastly, digital transformation plays a vital role in cost-cutting strategies; Allurion should further invest in technology that automates operations and reduces manual workload. AI-driven analytics can provide real-time insights into operational efficiency, helping the company make informed decisions about resource allocation. Yes, it requires upfront investment but will pay off in the long run by reducing operational costs and increasing productivity. The trend indicates that health tech companies that harness technology appropriately tend to outperform their peers.<\/p>\n<div style=\"border-left: 4px solid #2196f3; padding: 1em; border-radius: 4px; margin: 1.5em 0; background-color: #e3f2fd; color: #0d47a1; font-family: 'Noto Sans KR', sans-serif;\">\n<div style=\"font-weight: 700; margin-bottom: 0.5em; font-size: 1.1rem;\">\ud83d\udcdd Note<\/div>\n<p style=\"margin: 0; line-height: 1.6;\">By leveraging these strategies, Allurion Technologies can shape an improved outlook that not only addresses its current financial setbacks but also positions itself favorably for future growth in a rapidly changing market.<\/p>\n<\/div>\n<p><img decoding=\"async\" src=\"\" alt=\"\"><\/p>\n<h2 style=\"font-size: 1.8rem; font-weight: 700; color: #4a148c; margin-top: 1.5em; margin-bottom: 0.8em; line-height: 1.2; border-bottom: 3px solid #7b1fa2; padding-bottom: 0.3em; font-family: 'Noto Sans KR', sans-serif;\">The Strategic Shift Toward GLP-1 Therapy Explained<\/h2>\n<p class=\"styled-text\">In recent years, the landscape of obesity and metabolic disease treatment has been upended by a new class of medications known as GLP-1 (glucagon-like peptide-1) receptor agonists. These drugs, initially developed for diabetes management, have shown remarkable efficacy in promoting weight loss and improving metabolic health, making them a focal point for companies like Allurion Technologies. For those who are unaware, GLP-1 therapy mimics the effects of the natural hormones in the body that regulate appetite and insulin, providing a significant step forward in the treatment of obesity.<\/p>\n<p class=\"styled-text\">One of the best examples of this shift is seen with the recent performance of Allurion Technologies. Known for its innovative approaches, this company has faced challenges with revenue, particularly evident in Q2 2025. Yet, what many investors need to realize is how the market is pivoting toward GLP-1 therapies, and that includes understanding where companies like Allurion fit into the larger picture. As health and wellness take precedence in public discourse, the demand for effective weight loss solutions is surging. This pivot indicates that investors and stakeholders should keep a close eye on how Allurion aligns itself with or adapts to these trends. Through strategic partnerships and targeting the evolving needs of patients, there could be significant growth on the horizon, especially as more individuals seek long-term solutions for obesity-related health issues.<\/p>\n<p class=\"styled-text\">The introduction of GLP-1 drugs exemplifies a broader trend towards personalized medicine and targeted therapies. Instead of generic solutions, the conversation is increasingly about treatments tailored to individual patient profiles. This offers a dual benefit: not only are patients likely to experience better outcomes, but companies are incentivized to innovate further in this space. As an investor, keeping abreast of these developments is crucial. <strong style=\"font-weight: 700; color: #6a1b9a; font-family: 'Noto Sans KR', sans-serif;\">The shift towards GLP-1 therapy might just be the catalyst that revitalizes Allurion\u2019s market positioning.<\/strong> The implications for improving patient health while driving company growth cannot be understated.<img decoding=\"async\" class=\"aligncenter\" src=\"\" alt=\"\"><\/p>\n<h2 style=\"font-size: 1.8rem; font-weight: 700; color: #4a148c; margin-top: 1.5em; margin-bottom: 0.8em; line-height: 1.2; border-bottom: 3px solid #7b1fa2; padding-bottom: 0.3em; font-family: 'Noto Sans KR', sans-serif;\">Is Allurion Still a Viable Investment After the Reset?<\/h2>\n<p class=\"styled-text\">Allurion Technologies has seen a substantial <strong style=\"font-weight: 700; color: #6a1b9a; font-family: 'Noto Sans KR', sans-serif;\">71% revenue drop<\/strong> in Q2 2025 due to strategic realignment and shifts in distribution. This significant dip has left many investors questioning the viability of holding onto <strong style=\"font-weight: 700;\">Allurion Technologies stock<\/strong>. The uncertainty surrounding the company&#8217;s future prospects raises crucial questions: <mark style=\"background-color: #e1bee7; color: #6a1b9a; padding: 0 3px; border-radius: 2px; font-family: 'Noto Sans KR', sans-serif;\">Is Allurion still a good investment after this reset?<\/mark> Let\u2019s explore what this recent upheaval might mean for investors.<\/p>\n<h3 style=\"font-size: 1.8rem; font-weight: 700; color: #4a148c; margin-top: 1.5em; margin-bottom: 0.8em; line-height: 1.2; border-left: 5px solid #9c27b0; padding-left: 0.8em; font-family: 'Noto Sans KR', sans-serif;\">Understanding the Impact of Revenue Decline<\/h3>\n<p class=\"styled-text\">Since the unfortunate drop, Allurion has been <b style=\"font-weight: 700; color: #8e24aa; font-family: 'Noto Sans KR', sans-serif;\">strategically pivoting<\/b>. These shifts often lead to disillusionment among investors who rely on historical revenue trends. However, the company\u2019s management has indicated that they are focusing on rebuilding and optimizing their operational framework. It&#8217;s important to question whether the fundamental aspects of the business remain intact and whether upcoming innovations could reignite investor confidence.<\/p>\n<div style=\"border: 1px solid #e1bee7; padding: 1em; border-radius: 4px; margin: 1.5em 0; background-color: #f3e5f5; font-family: 'Noto Sans KR', sans-serif;\">\n<p style=\"margin: 0; line-height: 1.6;\">Remember, it\u2019s not the decline that defines a company&#8217;s future, but its capacity to innovate and adapt. Will Allurion be able to position itself favorably as digestion therapy evolves?<\/p>\n<\/div>\n<h4 style=\"font-size: 1.5rem; font-weight: 700; color: #ffffff; background-color: #6a1b9a; padding: 0.5em 1em; border-radius: 4px; width: 100%; box-sizing: border-box; margin-top: 1.5em; margin-bottom: 0.8em; line-height: 1.2; font-family: 'Noto Sans KR', sans-serif;\">Navigating the Future as an Investor<\/h4>\n<p class=\"styled-text\">As investors, we must weigh options carefully. Assessing <strong style=\"font-weight: 700;\">Allurion Technologies stock<\/strong> involves more than just the latest numbers; it\u2019s about understanding the company&#8217;s trajectory. If Allurion can effectively demonstrate a commitment to innovation, then the stock may offer long-term potential despite the recent downturn. Investors should engage with the company\u2019s narratives, scrutinize management strategies, and keep a keen eye on market trends that directly affect the company.<\/p>\n<div style=\"border: 1px solid #ff5722; padding: 1em; border-radius: 4px; margin: 1.5em 0; background-color: #fff3e0; color: #e64a19; font-family: 'Noto Sans KR', sans-serif;\">\n<div style=\"font-weight: 700; margin-bottom: 0.5em; font-size: 1.1rem;\">\u26a0\ufe0f Caution<\/div>\n<p style=\"margin: 0; line-height: 1.6;\">A significant revenue drop can alter perceptions quickly. Understanding your risk threshold and aligning it with your investment strategy is crucial during these turbulent times.<\/p>\n<\/div>\n<hr style=\"border: 0; height: 1px; background-image: linear-gradient(to right, rgba(156, 39, 176, 0), rgba(156, 39, 176, 0.75), rgba(156, 39, 176, 0)); margin: 2em 0;\">\n<p class=\"styled-text\">Ultimately, the questions posed to Allurion Technologies aren&#8217;t only about the past performance; they\u2019re about the confidence in the management\u2019s vision moving forward. Rebuilding trust can be challenging, but for those willing to take a second look, Allurion might still hold promise. The key takeaway? <b style=\"font-weight: 700;\">Monitor developments<\/b> closely and stay informed. The market can be unpredictable, but as knowledgeable investors, it\u2019s our job to adapt and learn continuously.<\/p>\n<details style=\"border: 1px solid #e1bee7; border-radius: 4px; margin: 1.5em 0; font-family: 'Noto Sans KR', sans-serif;\">\n<summary style=\"padding: 0.5em 1em; background-color: #f3e5f5; font-weight: 600; color: #6a1b9a; cursor: pointer;\">Q&amp;A: What Investors Need to Know Now<\/summary>\n<div style=\"padding: 1em;\">\n<div style=\"margin: 1.5em 0; font-family: 'Noto Sans KR', sans-serif;\">\n<div style=\"font-weight: 700; color: #9c27b0; margin-bottom: 0.5em; font-size: 1.1rem;\">\n        <span style=\"display: inline-block; width: 24px; height: 24px; line-height: 24px; text-align: center; background-color: #9c27b0; color: white; border-radius: 50%; margin-right: 8px;\">Q<\/span><br \/>\n        What should I do if I currently hold Allurion stocks?\n      <\/div>\n<div style=\"margin-left: 32px; margin-bottom: 1em;\">\n<p style=\"margin: 0; line-height: 1.6;\">Reassess your investment strategy and consider whether you believe in the future prospects of the company. Engaging in dialogues within investor communities can also provide varied insights.<\/p>\n<\/p><\/div>\n<div style=\"font-weight: 700; color: #6a1b9a; margin-bottom: 0.5em; font-size: 1.1rem;\">\n        <span style=\"display: inline-block; width: 24px; height: 24px; line-height: 24px; text-align: center; background-color: #6a1b9a; color: white; border-radius: 50%; margin-right: 8px;\">A<\/span><br \/>\n        Should I consider investing now with the recent dip?\n      <\/div>\n<div style=\"margin-left: 32px;\">\n<p style=\"margin: 0; line-height: 1.6;\">Investing during a downturn can yield opportunities, provided there&#8217;s validation in the company&#8217;s pivoting strategy. Always do your homework and consult financial advisors if uncertain.<\/p>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/details>\n<div style=\"text-align: center; margin: 2em 0;\">\n<a href=\"https:\/\/ggonggong.com\/\" style=\"display: inline-block; padding: 0.5em 1em; background-color: #9c27b0; color: white; text-decoration: none; border-radius: 4px; font-weight: 600; margin: 1em 0; font-family: 'Noto Sans KR', sans-serif;\">Continue<\/a>\n<\/div>\n<p style=\"text-align: center;\">#AllurionTech,#Investing,#StockMarket,#InvestmentStrategy,#FinancialAdvice<\/p>\n<p>  <!-- \ud478\ud130 --><\/p>\n<footer style=\"background-color: #f1f1f1; padding: 10px; text-align: center; font-size: 14px;\">\n<p>&copy; 2025 Ggonggong. All Rights Reserved.   Contact us at: <a href=\"mailto:admin@ggonggong.com\">admin@ggonggong.com<\/a><\/p>\n<\/footer>\n<\/footer>\n<p>  <!-- \uc2a4\ud06c\ub9bd\ud2b8 --><br \/>\n  <script src=\"scripts.js\"><\/script><br \/>\n<\/body><br \/>\n<\/html><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Allurion Technologies saw a 71% revenue drop in Q2 2025 due to strategic realignment and distribution changes. Learn what&#8217;s next for investors and where the company is heading.<\/p>\n","protected":false},"author":1,"featured_media":4556,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[34],"tags":[44],"class_list":["post-4555","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business-finance","tag-dailyprompt-1871"],"jetpack_publicize_connections":[],"_links":{"self":[{"href":"https:\/\/blog.ggonggong.com\/index.php?rest_route=\/wp\/v2\/posts\/4555","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.ggonggong.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.ggonggong.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.ggonggong.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.ggonggong.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4555"}],"version-history":[{"count":1,"href":"https:\/\/blog.ggonggong.com\/index.php?rest_route=\/wp\/v2\/posts\/4555\/revisions"}],"predecessor-version":[{"id":4557,"href":"https:\/\/blog.ggonggong.com\/index.php?rest_route=\/wp\/v2\/posts\/4555\/revisions\/4557"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/blog.ggonggong.com\/index.php?rest_route=\/wp\/v2\/media\/4556"}],"wp:attachment":[{"href":"https:\/\/blog.ggonggong.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4555"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.ggonggong.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4555"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.ggonggong.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4555"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}